The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies
about
Targeting xenobiotic receptors PXR and CAR in human diseasesInsights into CYP2B6-mediated drug-drug interactionsConstitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells.Drug metabolism and clearance system in tumor cells of patients with multiple myelomaSmall-molecule modulators of the constitutive androstane receptor.Small-molecule modulators of PXR and CAR.Transcriptional Regulation of CYP2B6 Expression by Hepatocyte Nuclear Factor 3β in Human Liver Cells.Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cellsGinseng alleviates cyclophosphamide-induced hepatotoxicity via reversing disordered homeostasis of glutathione and bile acid.Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma TreatmentAntiproliferation of berberine is mediated by epigenetic modification of constitutive androstane receptor (CAR) metabolic pathway in hepatoma cells.Flame retardant BDE-47 effectively activates nuclear receptor CAR in human primary hepatocytes.The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity.Targeting nuclear receptors with marine natural products.Signaling control of the constitutive androstane receptor (CAR)Immunology of chronic myeloid leukemia: current concepts and future goals.Nuclear receptors and drug metabolism for the personalization of cancer therapy.Molecular Basis of Metabolism-Mediated Conversion of PK11195 from an Antagonist to an Agonist of the Constitutive Androstane Receptor.Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine.Expression of NR1I3 in mouse lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone.
P2860
Q27012669-692E4BE7-BDDB-4CA3-96DC-864A98A7102AQ28078857-F6F58A25-54F7-4FF8-A302-FED684AD7049Q33799970-66167066-34A7-4520-B40D-6ECACB669FEAQ35742560-920625DA-3BCF-42CC-BED1-C874D8B37E7CQ35748820-C81CD86A-CB9D-4C40-8A04-379CCD273DC4Q35938150-87E35165-060B-40DD-B51E-E7AF9B468546Q35941376-E8E6F891-959E-4A1D-9C6B-E3F1373269EBQ36145585-61EF96A9-B75A-4393-840D-DF5366BA286CQ36340043-05CD9157-5FC3-40E3-8FF2-796F0364AB44Q36665092-EF5B208C-A226-49E0-B2EC-E8CB5B66DA99Q37014980-EE0DF297-7FD0-41BE-A96B-C4E62BF5ECD4Q37537458-A3858F89-C5CE-41B8-8654-5C714576E959Q37603877-C953740E-F982-4481-ACFE-FE92C41F4B88Q37621100-858A68AE-C7F8-4549-9193-619EB583D217Q37642162-7DC6CE14-440D-4F3F-81C9-66B08393CB8CQ38366539-86992D24-FD37-4925-B7B2-CC66B7688F55Q38704025-934C45A4-FA66-4668-A58E-664E9965EFEEQ38820078-83CEA2A8-ED38-4093-9898-0598ECDFE250Q38937177-DC8BBE7B-267B-47B5-9B1F-0CF2C84A4CE6Q42128778-6D61219D-149C-415B-AA5E-3AB5E79634C0
P2860
The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The constitutive androstane re ...... of hematopoietic malignancies
@ast
The constitutive androstane re ...... of hematopoietic malignancies
@en
type
label
The constitutive androstane re ...... of hematopoietic malignancies
@ast
The constitutive androstane re ...... of hematopoietic malignancies
@en
prefLabel
The constitutive androstane re ...... of hematopoietic malignancies
@ast
The constitutive androstane re ...... of hematopoietic malignancies
@en
P2093
P2860
P1433
P1476
The constitutive androstane re ...... of hematopoietic malignancies
@en
P2093
Hongbing Wang
Maria R Baer
Ronald B Gartenhaus
Stephen S Ferguson
P2860
P304
P356
10.1182/BLOOD-2012-06-436691
P407
P577
2012-11-16T00:00:00Z